Trial Profile
A Double-Blind, Randomized, Parallel-Arm, Multicenter Study to Determine the Dose Response of Methotrexate (MTX) in Combination Therapy With Adalimumab in Subjects With Early Rheumatoid Arthritis (CONCERTO)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms CONCERTO
- Sponsors Abbott Laboratories; AbbVie
- 02 Feb 2018 Results determining methotrexate polyglutamate concentrations and adalimumab pharmacokinetics, published in the Clinical Therapeutics.
- 23 Jun 2016 Results of safety analysis of this and other trials published in the Annals of the Rheumatic Diseases.
- 18 Feb 2014 Results published in the Annals of the Rheumatic Diseases.